UBS AM’s Colgate-Palmolive CL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $582M | Buy |
6,828,964
+811,750
| +13% | +$72.3M | 0.12% | 152 |
|
|
2025
Q4 | $475M | Sell |
6,017,214
-81,281
| -1% | -$6.37M | 0.1% | 167 |
|
|
2025
Q3 | $488M | Sell |
6,098,495
-1,083,552
| -15% | -$92.4M | 0.11% | 166 |
|
|
2025
Q2 | $653M | Buy |
7,182,047
+1,249,793
| +21% | +$114M | 0.13% | 144 |
|
|
2025
Q1 | $556M | Sell |
5,932,254
-367,735
| -6% | -$32.9M | 0.14% | 147 |
|
|
2024
Q4 | $573M | Buy |
6,299,989
+632,653
| +11% | +$60.4M | 0.13% | 137 |
|
|
2024
Q3 | $588M | Sell |
5,667,336
-365,109
| -6% | -$37.2M | 0.15% | 123 |
|
|
2024
Q2 | $585M | Buy |
6,032,445
+1,594,730
| +36% | +$147M | 0.17% | 107 |
|
|
2024
Q1 | $400M | Sell |
4,437,715
-507,776
| -10% | -$43M | 0.14% | 140 |
|
|
2023
Q4 | $394M | Buy |
4,945,491
+320,391
| +7% | +$24.1M | 0.16% | 129 |
|
|
2023
Q3 | $329M | Sell |
4,625,100
-848,602
| -16% | -$63.4M | 0.15% | 141 |
|
|
2023
Q2 | $411M | Hold |
5,473,702
| – | – | 0.2% | 107 |
|
|
2023
Q1 | $411M | Buy |
5,473,702
+357,898
| +7% | +$26.6M | 0.2% | 107 |
|
|
2022
Q4 | $403M | Sell |
5,115,804
-170,110
| -3% | -$12.8M | 0.21% | 105 |
|
|
2022
Q3 | $371M | Sell |
5,285,914
-171,997
| -3% | -$13.5M | 0.21% | 96 |
|
|
2022
Q2 | $437M | Buy |
5,457,911
+2,159
| +0% | +$169K | 0.23% | 83 |
|
|
2022
Q1 | $414M | Buy |
5,455,752
+318,105
| +6% | +$25.2M | 0.18% | 115 |
|
|
2021
Q4 | $438M | Buy |
5,137,647
+404,612
| +9% | +$31.6M | 0.17% | 126 |
|
|
2021
Q3 | $358M | Buy |
4,733,035
+149,053
| +3% | +$11.8M | 0.15% | 148 |
|
|
2021
Q2 | $373M | Buy |
4,583,982
+107,177
| +2% | +$8.76M | 0.16% | 136 |
|
|
2021
Q1 | $353M | Sell |
4,476,805
-68,643
| -2% | -$5.38M | 0.16% | 133 |
|
|
2020
Q4 | $389M | Buy |
4,545,448
+505,307
| +13% | +$41.8M | 0.18% | 111 |
|
|
2020
Q3 | $312M | Buy |
4,040,141
+80,032
| +2% | +$6.1M | 0.17% | 119 |
|
|
2020
Q2 | $290M | Sell |
3,960,109
-69,687
| -2% | -$4.95M | 0.18% | 116 |
|
|
2020
Q1 | $267M | Buy |
4,029,796
+346,472
| +9% | +$24.4M | 0.19% | 103 |
|
|
2019
Q4 | $254M | Buy |
3,683,324
+259,758
| +8% | +$17.7M | 0.16% | 128 |
|
|
2019
Q3 | $252M | Sell |
3,423,566
-49,440
| -1% | -$3.59M | 0.17% | 121 |
|
|
2019
Q2 | $249M | Sell |
3,473,006
-73,357
| -2% | -$5.21M | 0.18% | 110 |
|
|
2019
Q1 | $243M | Buy |
3,546,363
+236,829
| +7% | +$15.3M | 0.18% | 111 |
|
|
2018
Q4 | $197M | Buy |
3,309,534
+119,635
| +4% | +$7.48M | 0.17% | 123 |
|
|
2018
Q3 | $214M | Buy |
3,189,899
+24,080
| +0.8% | +$1.6M | 0.16% | 133 |
|
|
2018
Q2 | $205M | Sell |
3,165,819
-388,521
| -11% | -$25.4M | 0.16% | 143 |
|
|
2018
Q1 | $255M | Buy |
3,554,340
+69,888
| +2% | +$5.03M | 0.2% | 107 |
|
|
2017
Q4 | $263M | Buy |
3,484,452
+1,005,125
| +41% | +$73.4M | 0.22% | 96 |
|
|
2017
Q3 | $181M | Sell |
2,479,327
-29,869
| -1% | -$2.15M | 0.16% | 128 |
|
|
2017
Q2 | $186M | Sell |
2,509,196
-23,521
| -0.9% | -$1.75M | 0.18% | 125 |
|
|
2017
Q1 | $185M | Buy |
2,532,717
+253,665
| +11% | +$17.8M | 0.19% | 121 |
|
|
2016
Q4 | $149M | Sell |
2,279,052
-526,127
| -19% | -$36.1M | 0.17% | 136 |
|
|
2016
Q3 | $208M | Sell |
2,805,179
-86,569
| -3% | -$6.4M | 0.22% | 100 |
|
|
2016
Q2 | $212M | Sell |
2,891,748
-59,276
| -2% | -$4.22M | 0.24% | 92 |
|
|
2016
Q1 | $208M | Sell |
2,951,024
-92,492
| -3% | -$6.15M | 0.24% | 87 |
|
|
2015
Q4 | $203M | Sell |
3,043,516
-673,930
| -18% | -$44.8M | 0.23% | 86 |
|
|
2015
Q3 | $236M | Sell |
3,717,446
-356,168
| -9% | -$23.3M | 0.26% | 79 |
|
|
2015
Q2 | $266M | Sell |
4,073,614
-144,903
| -3% | -$9.83M | 0.26% | 89 |
|
|
2015
Q1 | $293M | Sell |
4,218,517
-159,081
| -4% | -$11M | 0.28% | 78 |
|
|
2014
Q4 | $303M | Sell |
4,377,598
-80,189
| -2% | -$5.42M | 0.29% | 78 |
|
|
2014
Q3 | $291M | Sell |
4,457,787
-16,319
| -0.4% | -$1.08M | 0.29% | 74 |
|
|
2014
Q2 | $305M | Buy |
4,474,106
+20,345
| +0.5% | +$1.36M | 0.31% | 70 |
|
|
2014
Q1 | $289M | Buy |
4,453,761
+168,750
| +4% | +$10.6M | 0.31% | 73 |
|
|
2013
Q4 | $279M | Buy |
4,285,011
+66,397
| +2% | +$4.25M | 0.32% | 70 |
|
|
2013
Q3 | $250M | Sell |
4,218,614
-662,351
| -14% | -$39.2M | 0.31% | 76 |
|
|
2013
Q2 | $280M | Buy |
+4,880,965
| New | +$290M | 0.36% | 62 |
|
Other funds holding CL
VCM
DAM
VPM
UBS AM's CL Position: Q1 2026 in Review
UBS AM increased its Colgate-Palmolive (CL) stake by 13% in Q1 2026, buying an estimated $72.3M and bringing the position to 6,828,964 shares worth $582M. The position accounts for 0.12% of the portfolio, ranked #152.
UBS AM first reported a position in CL in Q2 2013 and has held it in 52 quarters since. The position peaked at $653M in Q2 2025. 1,946 funds tracked by Wall St. Rank hold CL as of Q1 2026.
- UBS AM held 6,828,964 shares of Colgate-Palmolive worth $582M as of Q1 2026.
- UBS AM bought 811,750 Colgate-Palmolive shares in Q1 2026, an estimated $72.3M.
- Colgate-Palmolive made up 0.12% of UBS AM's portfolio in Q1 2026, its #152 holding.
- UBS AM first reported a position in Colgate-Palmolive in Q2 2013 and has held it in 52 quarters since.
- UBS AM's Colgate-Palmolive position peaked at $653M in Q2 2025.
- 1,946 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.
Based on UBS AM's 13F filing for Q1 2026, filed 13 May 2026.